Laps for Life Walk-a-thon for Brown University Oncology Research Group
Walk alone, walk with your family, walk with friends. All are welcome to the Laps for Life Walk-a-thon! Let’s fight together for a cure for cancer.
In 2012, more than 10,000 Rhode Islanders were diagnosed with cancer. Brown University Oncology Research Group is a world leader in developing new treatments for cancers of the pancreas, liver, brain, lung, breast and prostate. Let’s join together to help support clinical cancer trials.
When: May 4, 2014, 9:00-11:00 a.m., Registration begins at 8:00 a.m. Come rain or shine. Rain location Olney-Margolies Athletic Center, Hope Street, Providence.
Where: Ittleson Quadrangle, in front of Meehan Auditorium, Hope Street, Providence
What: Laps for Life is a 5K walk-a-thon. Feel free to walk less or more and at your own pace.
Registration for event: $25. All children under 5 are free. Register here.
Ask your friends and family members to sponsor you while you walk. All money raised will help support the creation and improvement of clinical trials for cancer.
Let’s all walk together for a cure!
Individual and corporate donations will be accepted for this event: Even if you cannot walk with us, we appreciate your support.
Please make checks payable to Brown University. “BrUOG Laps for Life” should be noted in the memo field.
Send checks to:
Brown University Oncology Research Group BrUOG:
Division of Biology & Medicine
Brown University
Box G-R001
Providence RI 02912
For more information on the Laps for Life Walk-a-thon, please contact [email protected] or [email protected].
About the Brown University Oncology Research Group:
The Brown University Oncology Research Group (BrUOG) was created in 1994 to coordinate clinical cancer research for Brown’s affiliated hospitals and Alpert Medical School faculty. BrUOG’s main mission is to improve cancer care through the implementation of innovative, multidisciplinary cancer clinical trials. BrUOG provides the infrastructure for the efficient development and implementation of these trials, which are created by Brown University faculty. Before BrUOG was founded, there was no unifying body for such research and no infrastructure through which Brown’s myriad scientists and physicians could share, advance, and garner support for their ideas on the treatment of cancer. The founding hospitals of BrUOG are Rhode Island Hospital, The Miriam Hospital, Roger Williams Medical Center, Memorial Hospital, and Women & Infants Hospital, which administer care to the majority of trial patients today. BrUOG, however, is the engine: its administrators and physicians provide support for the initial study concept and validation of trial design, and are responsible for trial administration, safety monitoring, data analysis, and the presentation and publication of findings.
The trials sponsored by BrUOG investigate novel, cutting-edge applications of chemotherapy, biologic agents and other cancer treatments. They study anticancer agents in early development, and as such are Phase I trials (which determine the optimally tolerated dose of an anticancer treatment regimen) or Phase II trials (which assesses the potential therapeutic effectiveness). These trials provide essential preliminary data for definitive Phase III trials, often conducted under the auspices of the National Cancer Institute.
